Literature DB >> 12517963

The GDP exchange factor AND-34 is expressed in B cells, associates with HEF1, and activates Cdc42.

Dongpo Cai1, Kyriakos N Felekkis, Richard I Near, Geraldine M O'Neill, Jean Maguire van Seventer, Erica A Golemis, Adam Lerner.   

Abstract

AND-34, a novel GDP exchange factor, is expressed constitutively at significant levels in murine splenic B cells, but not in murine splenic T cells or thymocytes. In B cell lines, anti-IgM treatment up-regulates AND-34 transcript levels. B cell AND-34 associates with both the docking molecules p130Cas and HEF1. AND-34 binds by its GDP exchange factor domain to the C terminus of HEF1, a region of HEF1 previously implicated in apoptotic, adhesion, and cell cycle-regulated signaling. Overexpression of AND-34 in murine B cell lines activates the Rho family GTPase Cdc42, but not Rac, Rho, RalA, or Rap1. Consistent with this, a subpopulation of AND-34 overexpressing B cells have long filamentous actin-containing cellular extensions. AND-34 overexpression augments both autophosphorylation and kinase activity of the Cdc42/Rac-responsive serine/threonine kinase PAK1. As previously reported for lymphoid cells transfected with constitutively active Cdc42, AND-34 overexpression inhibits SDF-1alpha-induced B cell polarization. These studies suggest that p130Cas and HEF1-associated AND-34 may regulate B cell adhesion and motility through a Cdc42-mediated signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12517963     DOI: 10.4049/jimmunol.170.2.969

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Splice variants and expression patterns of SHEP1, BCAR3 and NSP1, a gene family involved in integrin and receptor tyrosine kinase signaling.

Authors:  Virginie S Vervoort; Séverine Roselli; Robert G Oshima; Elena B Pasquale
Journal:  Gene       Date:  2007-01-08       Impact factor: 3.688

2.  BCAR3/AND-34 can signal independent of complex formation with CAS family members or the presence of p130Cas.

Authors:  Pierre Vanden Borre; Richard I Near; Anthony Makkinje; Gustavo Mostoslavsky; Adam Lerner
Journal:  Cell Signal       Date:  2011-01-22       Impact factor: 4.315

Review 3.  Preclinical and clinical studies of the NEDD9 scaffold protein in cancer and other diseases.

Authors:  Elena Shagisultanova; Anna V Gaponova; Rashid Gabbasov; Emmanuelle Nicolas; Erica A Golemis
Journal:  Gene       Date:  2015-05-09       Impact factor: 3.688

4.  Breast cancer anti-estrogen resistance 3 (BCAR3) protein augments binding of the c-Src SH3 domain to Crk-associated substrate (p130cas).

Authors:  Anthony Makkinje; Pierre Vanden Borre; Richard I Near; Prayag S Patel; Adam Lerner
Journal:  J Biol Chem       Date:  2012-06-18       Impact factor: 5.157

Review 5.  Pathways to tamoxifen resistance.

Authors:  Rebecca B Riggins; Randy S Schrecengost; Michael S Guerrero; Amy H Bouton
Journal:  Cancer Lett       Date:  2007-05-01       Impact factor: 8.679

6.  NSP-CAS Protein Complexes: Emerging Signaling Modules in Cancer.

Authors:  Yann Wallez; Peter D Mace; Elena B Pasquale; Stefan J Riedl
Journal:  Genes Cancer       Date:  2012-05

Review 7.  CAS proteins in normal and pathological cell growth control.

Authors:  Nadezhda Tikhmyanova; Joy L Little; Erica A Golemis
Journal:  Cell Mol Life Sci       Date:  2009-11-25       Impact factor: 9.261

Review 8.  CAS proteins in health and disease: an update.

Authors:  Anna S Nikonova; Anna V Gaponova; Alexander E Kudinov; Erica A Golemis
Journal:  IUBMB Life       Date:  2014-06-24       Impact factor: 3.885

9.  Pyk2 mediates endothelin-1 signaling via p130Cas/BCAR3 cascade and regulates human glomerular mesangial cell adhesion and spreading.

Authors:  Victoriya A Rufanova; Anna Alexanian; Tetsuro Wakatsuki; Adam Lerner; Andrey Sorokin
Journal:  J Cell Physiol       Date:  2009-04       Impact factor: 6.384

10.  AND-34/BCAR3 regulates adhesion-dependent p130Cas serine phosphorylation and breast cancer cell growth pattern.

Authors:  Anthony Makkinje; Richard I Near; Giuseppe Infusini; Pierre Vanden Borre; Alexander Bloom; Dongpo Cai; Catherine E Costello; Adam Lerner
Journal:  Cell Signal       Date:  2009-05-18       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.